Pari-based BioSerenity, a healthcare wearable developer, has secured 65 million euros ($74 million) in a Series B funding round.
Dassault Systèmes led the financing round with a total investment of $57 million.
BioSerenity plans to use the new capital to accelerate the development of sensor-equipped wearables and associated telehealth solutions in the fields of cardiology, neurology and sleep disorders.
Additionally, the company will also use the money raised from the funding round, which saw other backers including Bpifrance, Idinvest and LBO France participate in the round, to grow its business globally.